 |
chemically modified recombinant sulfamidase |
|---|---|
| Trade Name | |
| Orphan Indication | Mucopolysaccharidosis type IIIA (MPS IIIA) |
| USA Market Approval | USA |
| USA Designation Date | 2017-06-28 00:00:00 |
| Sponsor | Swedish Orphan Biovitrum AB (publ);D�NSKEBO;Link�ping SV |
| |
chemically modified recombinant sulfamidase |
|---|---|
| Trade Name | |
| Orphan Indication | Mucopolysaccharidosis type IIIA (MPS IIIA) |
| USA Market Approval | USA |
| USA Designation Date | 2017-06-28 00:00:00 |
| Sponsor | Swedish Orphan Biovitrum AB (publ);D�NSKEBO;Link�ping SV |